Over 800 adverse effects of implants reported in 2018 The Dutch Reporting centre for adverse effects of medical implants (MEBI) received 162 reports of suspected adverse effects of implants. The notifications were linked to 181 implants.
Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.
iGEM meetup for teams and supervisors The best synbio projects, including iGEM teams, have one thing in common: cutting edge science in the light of carefully considered societal needs.
Global Infectious Disease Control hampered by the CBD Nagoya Protocol So far, none of the models used by international networks of biobanks to arrange the legal responsibility under the CBD-Nagoya protocol works efficiently.
Tuberculosis in the spotlights A large international congress on tuberculosis will start in The Hague on October 24.
RIVM visits German Environment Agency (UBA) On 17 and 18 October 2018, RIVM visited the German Environment Agency Umwelt Bundesamt (UBA).
The introduction of the colorectal cancer screening programme in the Netherlands In 2014, a colorectal cancer screening programme was launched in the Netherlands. In a factsheet we describe the lessons learned during the introduction of this nationwide programme.
Sustainability Day at RIVM: Microplastics Today, 10 October 2018, is national Sustainability Day in the Netherlands.
Issue 2 of our newsletter is out now! Issue 2 of our quarterly newsletter is out now. It features the best read news stories and background information on public health and the environment from RIVM in the third quarter of 2018.
Alternatives available for environmentally detrimental antifouling paints There are various systems without biocides available that can serve as alternatives for antifouling paints on pleasure boats to prevent the growth of algae and shellfish on the hull.